SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-236522
Filing Date
2022-09-01
Accepted
2022-09-01 16:14:03
Documents
12
Period of Report
2022-08-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d248228d8k.htm   iXBRL 8-K 23781
  Complete submission text file 0001193125-22-236522.txt   144966

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA omga-20220831.xsd EX-101.SCH 2874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE omga-20220831_lab.xml EX-101.LAB 17978
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omga-20220831_pre.xml EX-101.PRE 11270
6 EXTRACTED XBRL INSTANCE DOCUMENT d248228d8k_htm.xml XML 3347
Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Filer) CIK: 0001850838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40657 | Film No.: 221221099
SIC: 2836 Biological Products, (No Diagnostic Substances)